New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo (original) (raw)
Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science278, 1295–1300 (1997). ArticleCAS Google Scholar
Wong, J.K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science278, 1291–1295 (1997). ArticleCAS Google Scholar
Chun, T.W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA94, 13193–13197 (1997). ArticleCAS Google Scholar
Siliciano, J.D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med.9, 727–728 (2003). ArticleCAS Google Scholar
Strain, M.C. et al. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. USA100, 4819–4824 (2003). ArticleCAS Google Scholar
Richman, D.D. et al. The challenge of finding a cure for HIV infection. Science323, 1304–1307 (2009). ArticleCAS Google Scholar
Deeks, S.G. et al. Towards an HIV cure: a global scientific strategy. Nat. Rev. Immunol.12, 607–614 (2012). ArticleCAS Google Scholar
Karn, J. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr. Opin. HIV AIDS6, 4–11 (2011). Article Google Scholar
Hakre, S., Chavez, L., Shirakawa, K. & Verdin, E. HIV latency: experimental systems and molecular models. FEMS Microbiol. Rev.36, 706–716 (2012). ArticleCAS Google Scholar
Archin, N.M. et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses25, 207–212 (2009). ArticleCAS Google Scholar
Bartholomeeusen, K., Fujinaga, K., Xiang, Y. & Peterlin, B.M. Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J. Biol. Chem.288, 14400–14407 (2013). ArticleCAS Google Scholar
Contreras, X. et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J. Biol. Chem.284, 6782–6789 (2009). ArticleCAS Google Scholar
Shirakawa, K., Chavez, L., Hakre, S., Calvanese, V. & Verdin, E. Reactivation of latent HIV by histone deacetylase inhibitors. Trends Microbiol.21, 277–285 (2013). ArticleCAS Google Scholar
Doyon, G., Zerbato, J., Mellors, J.W. & Sluis-Cremer, N. Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog. AIDS27, F7–F11 (2013). ArticleCAS Google Scholar
Xing, S. et al. Disulfiram reactivates latent HIV-1 in a BCL-2–transduced primary CD4+ T cell model without inducing global T cell activation. J. Virol.85, 6060–6064 (2011). ArticleCAS Google Scholar
Banerjee, C. et al. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J. Leukoc. Biol.92, 1147–1154 (2012). ArticleCAS Google Scholar
Boehm, D. et al. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle12, 452–462 (2013). ArticleCAS Google Scholar
Li, Z., Guo, J., Wu, Y. & Zhou, Q. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res.41, 277–287 (2013). ArticleCAS Google Scholar
Zhu, J. et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell Reports2, 807–816 (2012). ArticleCAS Google Scholar
Korin, Y.D., Brooks, D.G., Brown, S., Korotzer, A. & Zack, J.A. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol.76, 8118–8123 (2002). ArticleCAS Google Scholar
Kulkosky, J. et al. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood98, 3006–3015 (2001). ArticleCAS Google Scholar
Williams, S.A. et al. Prostratin antagonizes HIV latency by activating NF-κB. J. Biol. Chem.279, 42008–42017 (2004). ArticleCAS Google Scholar
DeChristopher, B.A. et al. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nat. Chem.4, 705–710 (2012). ArticleCAS Google Scholar
Kinter, A.L., Poli, G., Maury, W., Folks, T.M. & Fauci, A.S. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol.64, 4306–4312 (1990). CASPubMedPubMed Central Google Scholar
Mehla, R. et al. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS ONE5, e11160 (2010). Article Google Scholar
Archin, N.M. et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature487, 482–485 (2012). ArticleCAS Google Scholar
Blazkova, J. et al. Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4+ T cells from infected individuals receiving effective antiretroviral therapy. J. Infect. Dis.206, 765–769 (2012). Article Google Scholar
Rasmussen, T.A., Tolstrup, M., Winckelmann, A., Ostergaard, L. & Sogaard, O.S. Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials. Hum. Vacc. Immunother.9, 790–799 (2013). ArticleCAS Google Scholar
Spivak, A.M. et al. A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1–infected adults on antiretroviral therapy. Clin. Infect. Dis. 10.1093/cid/cit813 (12 December 2013).
Moriuchi, H., Moriuchi, M. & Fauci, A.S. Induction of HIV replication by allogeneic stimulation. J. Immunol.162, 7543–7548 (1999). CASPubMed Google Scholar
Laird, G.M. et al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog.9, e1003398 (2013). ArticleCAS Google Scholar
Han, Y. et al. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol.78, 6122–6133 (2004). ArticleCAS Google Scholar
Schröder, A.R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell110, 521–529 (2002). Article Google Scholar
Baba, M., Miyake, H., Okamoto, M., Iizawa, Y. & Okonogi, K. Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res. Hum. Retroviruses16, 935–941 (2000). ArticleCAS Google Scholar
Yang, H.C. et al. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J. Clin. Invest.119, 3473–3486 (2009). CASPubMedPubMed Central Google Scholar
Shan, L. et al. A novel PCR assay for quantification of HIV-1 RNA. J. Virol.87, 6521–6525 (2013). ArticleCAS Google Scholar